PPARG (Peroxisome Proliferator-Activated Receptor Gamma)
PPARG
Nuclear receptor regulating glucose and lipid metabolism, adipocyte differentiation.
Funktion
Thiazolidinediones (pioglitazone) activate PPARG to improve insulin sensitivity.
Arzneimittel, die auf dieses Target wirken
| Arzneimittel | Wirkung | Primär |
|---|---|---|
| Methylprednisolone | Agonist | Ja |
| Insulin Glargine | Agonist | Ja |
| Liraglutide | Agonist | Ja |
| Semaglutide | Agonist | Ja |
| Tirzepatide | Agonist | Ja |
| Prednisone | Agonist | Ja |
| Dexamethasone | Agonist | Ja |
| Levothyroxine | Agonist | Ja |
| Spironolactone | Antagonist | Ja |
| Tamoxifen | Antagonist | Ja |
| Sitagliptin | Inhibitor | Ja |
| Finasteride | Inhibitor | Ja |
| Empagliflozin | Inhibitor | Ja |
| Metformin | Other | Ja |
| Montelukast | Other | — |